Key Takeaways
- A business built for the long game, but the short term is all investment: Consolidated EBITDA swung to a loss of INR 34 crores as the company scaled up care homes, new geographies, and AGEasy, while the residential business had no inventory to sell.
- The Gurgaon care home finally turned the corner: Unit economics jumped from minus 1% to 16% margin in two quarters, and occupancy broke a two-year stagnation to hit 71% in April, proving the model in a tough North Indian market.
- The pipeline is now a real, funded thing: With INR 330 crores approved for infusion, the company has a line of sight to 600 care home beds by FY25-end, two new residential community launches, and a multi-city care-at-home footprint.
- AGEasy is a bet, not yet a business: It has served 26,000 customers and is CM1 positive, but management declined to share contribution margin, ROAS, or capital employed, calling it "too early."
- What to watch next quarter: The Gurgaon residential launch in Q2 FY25, which must bridge the consolidated revenue dip; the Bannerghatta care home ramp-up; and any hard numbers on AGEasy's unit economics.
The Integrated Care Ecosystem Bet
- Full-stack thesis: Max India is building the only integrated senior care ecosystem in India, spanning independent living, assisted care, home healthcare, and a D2C products brand, so it can serve a customer across changing needs and capture lifetime value.
- External validation: A recent Blume Ventures paper argued that full-stack is the winning model in elder care, a view management says vindicates its vision.
- The challenge: This breadth means the company is simultaneously investing in multiple asset-heavy and asset-light verticals, compressing near-term profitability while the pieces scale.
Rajit Mehta: "We are the only organization in India trying to create an integrated care ecosystem for seniors. Our belief is that seniors' needs will change with age and medical condition. And therefore, once they become our customers, we should be able to serve them through many means, through many products and services."
Residential Communities: The Near-Term Revenue Bridge
- The revenue gap: Consolidated revenue dipped because the company had no inventory to sell after Dehradun and Noida Phase 1 sold out; this is a temporary phenomenon that the Gurgaon launch in Q2 FY25 is meant to bridge.
- Dehradun delivered: 100% inventory sold, 189 of 197 apartments handed over, 180+ residents, and the project is PBT and cash positive with a surplus of INR 125 crores.
- Noida Phase 1: All inventory sold since March 2023, collections running at 99% efficiency, and construction on track with block work complete across all three towers.
- The next wave: Gurgaon, North India's first intergenerational project (senior living plus regular housing developed by Max Estates), is in prelaunch with RERA approval applied for and launch expected in Q2 FY25. Bengaluru is targeted for Q4 FY25, pending financial closure.
- Project IRRs: Both Gurgaon and Bengaluru are targeted at 22-24%, and Noida Phase II pricing is expected to be above the current market range of INR 11,500-12,000 per sq ft, with a potential upside to IRR once costs are reviewed post-RERA approval.
- Ambition: The company aims to develop 0.15 crore sq ft every year for the next 3-4 years, targeting 8-10 communities and 4,000-5,000 senior living units over 5-7 years.
Care Homes: The Unit Economics Inflection
- Gurgaon proved the model: Margins moved sharply from minus 1% in Q2 FY24 to 16% in Q4 FY24, and occupancy jumped from a stagnant 58-59% to 71% in April after two years of category-building in North India.
- Why it was stuck: The care home category has taken longer to establish in North India versus South and West, where demand is higher and the category is fully established; Max India is the first mover with nearly 200 beds in the North by August.
- The replication plan: 600 beds are expected to be operational by FY25-end across Bengaluru (Bannerghatta: 83 beds by June, Whitefield: 85 beds by Q3), Noida (53 beds by July/August), Gurgaon (98 beds by Q2), and Chennai (about 200 beds by Q4). LOIs are signed for all except Chennai.
- Bannerghatta launch readiness: The facility is open for show-arounds, tie-ups with most large Bengaluru hospitals are done, and a digital and offline go-to-market campaign is underway, though management declined to give forward-looking occupancy guidance.
- Target margin at scale: At 70-75% occupancy, contribution-level margin is expected to be upwards of 23-24%.
Rajit Mehta: "In North, it has taken a while for this category to come up. So if you look at most players, they haven't expanded in the North. We're the only ones who now have -- almost 200 beds by August in North. We will be the first ones."
AGEasy & MedCare: The D2C Bet on Senior Products
- MedCare is a niche winner: Revenue grew over 100% YoY because no other company in India specializes in or customizes products for seniors across a full mobility range (walkers, walking sticks, wheelchairs), with features tailored to material, grip, and safety.
- AGEasy traction is real but unquantified: The brand has served 26,000 customers, generated 2,600 repeat orders, achieved an NPS of 50, and has 12 products rated 4 stars on Amazon, but management called it "too early" to share contribution margin, ROAS, or capital employed.
- Path to profitability: The business is already CM1 positive; management pointed to market analogies like Mosaic Wellness, which becomes EBITDA positive at a INR 20-25 crore monthly run rate, but offered no timeline for AGEasy itself.
- FY25 expansion: Two new chronic conditions (respiratory health and diabetes) will launch, and listings on Flipkart and Tata 1mg are planned, with the back end for MedCare and AGEasy now consolidated across warehousing, logistics, and procurement.
Care at Home: The High-Margin Services Engine
- Growth drivers: Revenue growth came from deeper NCR penetration, a mix shift toward higher-margin services (critical care, nursing, patient caregiver services), and the launch of services in Bengaluru and Chennai.
- FY25 outlook: Management expects double-digit growth because Bengaluru and Chennai, launched only 4 and 8 months ago, have significant headroom for deeper penetration, and Delhi NCR still has room to go deeper.
- Strategic fit: This is the services layer that keeps the Antara brand embedded with customers who may not yet need a care home, feeding the integrated ecosystem thesis.
Financial Health & Capital Allocation
- The loss is a choice: The consolidated EBITDA loss of INR 34 crores (vs. a gain of INR 12 crores last year) was driven by deliberate scale-up: ramping care homes, entering Bengaluru and Chennai, and scaling AGEasy, with losses contained through cost optimization and treasury management.
- Employee cost breakdown: Human capital expense rose INR 24 crores YoY, of which INR 7 crores came from Antara Senior Living (partly ESOPs, partly variable pay on strong performance), Antara Assisted Care invested in team-building for AGEasy and new geographies, and INR 3 crores on the corporate side (INR 2 crores of which was non-cash ESOPs).
- Capital infusion: INR 330 crores approved, with INR 180 crores earmarked for Antara Assisted Care and incidental businesses, and INR 150 crores for the residential vertical.
- No capital raise yet: Management said a raise could come when scale-up and growth materialize, but nothing is confirmed.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Gurgaon residential community launch | Prelaunch activities ongoing; RERA approval applied for | Q2 FY25 |
| Bengaluru residential community launch | Definitive agreement closed; awaiting financial closure from bankers | Q4 FY25 |
| Care home beds operational | 600 beds across Bengaluru, Noida, Gurgaon, Chennai | By FY25 year-end |
| AGEasy condition expansion | Launch respiratory health and diabetes categories | FY25 |
| AGEasy e-commerce listing | Initiate listing on Flipkart and Tata 1mg | FY25 |
| Care at Home geographic expansion | Expand footprint in NCR, Bengaluru, Chennai | FY25 |
| Residential development cadence | 0.15 crore sq ft developed every year | Next 3-4 years |
| Long-term portfolio target | 8-10 communities, 4,000-5,000 senior living units, 1,500-2,000 care home beds, 50+ health studios | 5-7 years |
Key Metrics
| Metric | Q4 FY24 |
|---|---|
| Consolidated revenue | Not stated; FY24 consolidated EBITDA loss of ₹34 cr vs gain of ₹12 cr last year |
| Antara Assisted Care net revenue | ₹8.6 cr, +94% YoY from ₹4.5 cr in Q4 FY23 |
| Care Homes net revenue | ₹1.4 cr, +4% YoY (adjusted for inoperative care homes) |
| Care Homes contribution margin | 2%, improved from 0% in Q4 FY23 (adjusted) |
| Care at Home net revenue | ₹3.0 cr, +97% YoY |
| Care at Home contribution margin (NCR) | 19% |
| MedCare net revenue | ₹2.7 cr, +106% YoY |
| MedCare contribution margin | -5%, driven by old inventory disposal |
| AGEasy net revenue | ₹1.43 cr, +53% QoQ from ₹0.95 cr in Q3 FY24; ARR of ₹6 cr within 6 months of launch |
| Gurgaon Care Home unit contribution margin | 16%, up from -1% in Q2 FY24 |
| Gurgaon Care Home occupancy | 59% in Q4 FY24; rose to 71% in April |
| Gurgaon Care Home average realization per bed per day | Above ₹6,000, ranging ₹5,500–₹6,300 |
| Gurgaon Care Home cross-sell of services | 38% vs expected 10% |
| Treasury and monetizable assets | ₹435 cr as of March '24 |
| Consolidated net worth | ₹492 cr as of March '24 |
| Dehradun community operational revenue (FY24) | ₹22 cr, +32% YoY |
| Dehradun community cash surplus | ₹125 cr as of March '24 |
| Dehradun community RSAT score | 90%; 40% of sales via resident referrals |
| Noida Phase 1 cumulative collections | ₹342 cr since inception, +36% YoY; 99% collection efficiency |
| Care at Home lives served since inception | 14,500 |
| AGEasy customers served | More than 26,000; 2,600 repeat customers |
| AGEasy NPS score | 53 |
| MedCare SKUs | 800-plus, including Antara-labeled products |
| Antara Assisted Care patients served (cumulative) | About 50,000 |
| Beds operational (current) | 68 |
| Beds planned by FY25 year-end | ~600 |
| Gurugram senior living project | 292 apartments, 0.07 cr sq ft; launch expected Q2 FY25 |
| Bengaluru senior living project | 544 units, 0.11 cr sq ft; launch expected Q4 FY25 |
| Target annual development | 0.15 cr sq ft per year for next 3–4 years |
| IRR target for upcoming projects | 22–24% for Gurgaon and Bengaluru |
| Noida market selling price (Antara-like standards) | ₹11,500–₹12,000 per sq ft |
| Marketing spend (new businesses) | 7–8% of sales |
| Marketing spend (mature real estate) | Not more than 3–4% of total revenue |
| Approved infusion into Antara Assisted Care | ₹180 cr |
| Approved infusion into residential vertical | ₹150 cr |
| Employee expense increase (FY24 vs FY23) | ₹24 cr; ₹7 cr Antara Senior Living, ₹3 cr corporate (₹2 cr ESOPs, non-cash) |
| Senior housing demand (Colliers study) | 18–20 lakh units |
| Elder care market size | $10 bn–$12 bn; AGEasy addressable market ₹40,000 cr in top 30 cities Sec A/B |